Serum BCM Levels in Patients with Non-tumoral Pathologies: A Value of 25 U/ml can be Used as Threshold for Tumoral Activity

Abstract

Get full access to this article

View all access options for this article.

References

Anderson

, Slota

, Kundu

Characterization of monoclonal antibodies to paragloboside and sialosyl-PG and an improved chromatogram binding assay for rapidly identifying antibodies to tumor antigens. J Cell Biochem Suppl 1987; 110: 157.

Papsidero

L.D.

, Croghan

G.A.

, O'Connell

M.J.

, Valenzuela

L.A.

, Nemoto

, Chu

T.M.

Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma. Cancer Res 1983; 43: 1742–7.

Konrath

, Kinders

, Kim

Breast cancer marker (BCM) assay: correlation with clinical course. Breast Cancer Symposium (Abstract). San Antonio, Texas. 1987.

Daver

, Lennartz

, Bellia

, Dalifard

, Lemieux

, Page

Comparison of a new marker, BCM-EIA, to CA 15.3 and MCA for detection and monitoring of breast cancer patients ISO BM Congress. Abstract Freiburg 1989.